Buy BioCryst Pharmaceuticals Stock | BCRX Stock Price & Latest News | Public
BCRX

BioCryst Pharmaceuticals

$0.00 (0.00%)Today

    About BCRX

    BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquarter...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.08
    -0.17
    -0.25
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$0.25

    Actual EPS
    Q3 2020

    Stats

    Market Cap$642,7M
    Volume198,53k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$6.29
    1 Year Low$1.38
    Open$3.43
    High$3.64
    Low$3.43

    Buy any stock with any amount of money.

    Download the App
    Download the app